The CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) biotechnology market is a rapidly growing industry driven by the increasing demand for biologics, such as monoclonal antibodies and vaccines, and the need for cost-effective and efficient production of these complex molecules.
CMOs and CDMOs provide a range of services to biotechnology and pharmaceutical companies, including process development, scale-up, and commercial manufacturing of biologics. They offer a cost-effective solution for companies that lack the resources and infrastructure to produce these complex molecules in-house, and also provide access to specialized expertise and equipment.
Global revenue from the CMO/CDMO biotechnology market stands at US$ 10.2 Bn in 2022, with the worldwide market estimated to surge ahead at a CAGR growth value of 11.6% to reach a valuation of around US$ 34.1 Bn by the end of 2033.
Request For Free Sample Report of “CMO/CDMO Biotechnology Market”@ https://www.persistencemarketresearch.com/samples/32516
CMOs and CDMOs are companies that provide manufacturing and development services for other biotech companies. These services can include everything from research and development to full-scale commercial production. CMOs and CDMOs allow biotech companies to outsource certain aspects of their operations, freeing up resources and allowing them to focus on their core competencies.
The demand for CMO/CDMO services has grown in recent years due to a number of factors. One major driver is the increasing complexity and cost of biotech manufacturing. As biotech products become more advanced and specialized, the cost of developing and producing them has risen. CMOs and CDMOs can provide the expertise and resources needed to manufacture these products at a lower cost than many biotech companies could on their own.
Companies
- Patheon N.V.
- Catalent
- Samsung Biologics Co., Ltd
- Boehringer Ingelheim
- Samsung BioLogics
- AGC Biologics, Inc.
- WuXi Biologics
- AbbVie Inc
- Avid Bioservices, Inc.
- Fujifilm Diosynth Biotechnologies
- Xpress Biologic
- Rentschler Biopharma SE
- KBI Biopharma (JSR Corporation)
- Cytovance Biologics
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/32516
Another factor driving demand for CMO/CDMO services is the increasing regulatory burden faced by biotech companies. Regulations governing the development and production of biotech products are becoming more stringent, and compliance can be costly. CMOs and CDMOs can provide assistance in navigating these regulations and ensuring that products are developed and produced in compliance with them.
In addition, CMO/CDMO biotechnology market has many benefits for Small Biotech companies by giving them access to state-of-the-art manufacturing facilities, experienced personnel, and established processes. They also provide a valuable safety net for these companies, allowing them to continue operations even in the event of unexpected disruptions.
Competitive Landscape
Key players are concentrating on expansion in emerging regions and new revised product manufacturing. Market participants are also working to strengthen their expansion, new product launches, and improved distribution channels such as online sources of advertisement.
For instance:
- For instance, Iovance Biotherapeutics chose Avid Bioservices in August 2020 to spearhead process development through cGMP manufacture of IOV-3001, an innovative anti-cancer medication candidate and new IL-2 analogue.
- Fujifilm Diosynth Biotechnologies in April 2021, announced the establishment of its new Microbial production facility in the U.K. The aim of this expansion was to triple the existing microbial production. This new production facility was equipped with 2*2000L of fermenters and modular purification suits.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/32516
Key Segments Covered in CMO/CDMO Biotechnology Industry Research
By Service:
- Stand-Alone Services
- Cell-line development
- Development and Bio manufacturing
- Analytical Services
- Fill Finish
- Packaging
- Clinical Supply Services
- Integrated
By Product:
- Monoclonal Antibodies
- Antibody Fragments
- Recombinant Therapeutic Proteins
- Viral Vector
- Cell and Gene Therapy
- Vaccine
By Expression System:
- Mammalian
- Microbial
- Bacteria
- Yeast
By Company Size:
- Small
- Mid-Sized
- Large
- Very Large
By Scale of Operations:
- Pre-clinical
- Clinical
- Commercial
For More Premium Insights, Check out the Link:
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353